Brain47Brain47Join Brain47
2BO

2BO

Healthcare · EUR · F

2BO

Price

€1.522

+17.80%

Cap

€26.07M

Earnings

—

30d Trend

-10.3%

2BO
Loading chart data...
0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

0
MODERATE
Risk Level85
Quality37
Momentum78
Technical57
Fundamentals64

Raw weighted: 55×Macro 0.99 (−1%)=54

RISK

85/100
90d Volatility
132.2%High
ATR %
10.8%High daily moves
Max Drawdown (1Y)
-55.6%Volatile

QUALITY

37/100
ROE (avg)
-28.1%Negative
Piotroski F-Score
3/9Weak
Accruals
-23.1%Cash earnings

MOMENTUM

78/100
12-1M Momentum
+29.6%Strong uptrend
6-1M Momentum
+29.6%Positive
1M Return
-14.0%Sharp decline
Relative Strength
-1.1% vs sectorIn-line

TECHNICAL

57/100
RSI (14)
45.9Neutral
Price vs SMA200
+15.6%Bullish trend
MACD
0.00Bearish momentum
Bollinger Band
37%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.185Noisy/choppy

FUNDAMENTALS

64/100
P/S
11.1Expensive
PEG
0.15Growth at discount
Shareholder Yield
7.3%Strong returns

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months38
3-12 months ★60
1-5+ years53

6-9 month opportunity — emerging trend

BRAIN47'S ASSESSMENT

I rate 2BO at 54/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 78/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

DETAILED ANALYSIS

6-9 month opportunity — emerging trend. Momentum (78) and Fundamentals (64) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 54/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.